ClinicalTrials.Veeva

Menu

Genetic Polymorphisms of Interleukin-10 and TNF-α on Outcome of HCV-Related Chronic Liver Disease

K

Kaohsiung Medical University

Status

Unknown

Conditions

Chronic Liver Disease
Hepatitis C Virus Infection

Treatments

Genetic: TNF-alpha and IL-10

Study type

Interventional

Funder types

Other

Identifiers

NCT00630006
KMUH-IRB-950182

Details and patient eligibility

About

The prognosis of chronic hepatitis C virus (HCV)infeciton varies from minimal progressive disease to cirrhosis or hepatocellular carcinoma. Host genetic factors contribute to disease severity. It is known that cytokine gene (including tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) polymorphism affect disease prognosis.This study aims to assess the effect of TNF-alpha and IL-10, and their interaction,on prognosis of HCV-related chronic liver disease

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Anti-HCV-positive patients

Exclusion criteria

  • Anti-HCV-negative patients

Trial contacts and locations

1

Loading...

Central trial contact

Jen-Eing Jeng, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems